Irdabisant (INN, USAN; developmental code name CEP-26401) is a histamine H3 receptor antagonist and inverse agonist which was under development for the treatment of cognition disorders but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.